Physician profile
Ross Patrick Vimr
NPI 1467719641
$10,875.60
in general payments reported to CMS, 2019-2025
11 companies · $368 in 2025
The $368 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,104 · 2020: $2,196 · 2021: $128 · 2022: $223 · 2023: $369 · 2024: $487 · 2025: $368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,224.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $8,663.51 | 2019-2020 | |
| Edwards Lifesciences Corporation | $726.17 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abbott Laboratories | $595.34 | 2019-2024 | Mitraclip, Amplatzer Talisman |
| Biotronik INC. | $293.70 | 2019-2020 | |
| Cardiovascular Systems INC. | $151.38 | 2020 | |
| Shockwave Medical, INC | $150.90 | 2025 | |
| W. L. Gore & Associates, INC. | $138.25 | 2022 | |
| Philips North America LLC | $56.48 | 2022-2023 | |
| Abiomed | $50.92 | 2025 | |
| Penumbra, INC. | $30.33 | 2022-2024 | Penumbra System |
| Terumo Medical Corporation | $18.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ross Vimr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.